1. Home
  2. VNDA vs VYGR Comparison

VNDA vs VYGR Comparison

Compare VNDA & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

N/A

Current Price

$3.99

Market Cap

231.0M

Sector

Health Care

ML Signal

N/A

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

N/A

Current Price

$1.72

Market Cap

193.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VNDA
VYGR
Founded
2002
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
231.0M
193.5M
IPO Year
2005
2015

Fundamental Metrics

Financial Performance
Metric
VNDA
VYGR
Price
$3.99
$1.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
11
Target Price
$11.50
★ $14.22
AVG Volume (30 Days)
★ 1.3M
1.0M
Earning Date
10-28-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $216,105,000.00
$10,135,000.00
Revenue This Year
$12.05
N/A
Revenue Next Year
$30.61
$164.37
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 8.72
N/A
52 Week Low
$3.57
$1.68
52 Week High
$9.91
$5.19

Technical Indicators

Market Signals
Indicator
VNDA
VYGR
Relative Strength Index (RSI) 43.50 37.62
Support Level $3.57 $1.68
Resistance Level $5.49 $2.29
Average True Range (ATR) 0.28 0.13
MACD 0.05 0.03
Stochastic Oscillator 34.42 28.89

Price Performance

Historical Comparison
VNDA
VYGR

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: